Nature Publishing Group, publisher of Nature, and other science journals and reference works
Nature
my account e-alerts subscribe register
   
Saturday 11 July 2009
Journal Home
Current Issue
AOP
Archive
Download PDF
References
Export citation
Export references
Send to a friend
More articles like this

Letters to Nature
Nature 366, 751 - 756 (30 December 1993); doi:10.1038/366751a0

Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats

Bostjan Kobe & Johann Deisenhofer

Howard Hughes Medical Institute and Department of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75235-9050, USA

RIBONUCLEASE inhibitor is a cytoplasmic protein that tightly binds and inhibits ribonucleases of the pancreatic ribonuclease super-family1. The primary sequence of this inhibitor contains leucine-rich repeats2 (LRRs); these motifs are present in many proteins that participate in protein–protein interactions and have different functions and cellular locations. In vivo, ribonuclease inhibitor may have a role in the regulation of RNA turnover in mammalian cells3 and in angiogenesis4. To define the structural features of LRR proteins and to understand better the nature of the tight interaction of ribonuclease inhibitor with ribonucleases, we have determined the crystal structure of the porcine inhibitor. To our knowledge, this is the first three-dimensional structure of a protein containing LRRs and represents a new class of alpha/beta protein fold. Individual repeats constitute betaalpha structural units that probably also occur in other proteins containing LRRs. The non-globular shape of the structure and the exposed face of the parallel beta-sheet may explain why LRRs are used to achieve strong protein–protein interactions. A possible ribonuclease-binding region incorporates the surface formed by the parallel beta-sheet and the betaalpha loops.

------------------

References
1. Lee, F. S. & Vallee, B. L. Prog. Nucleic Acids Res. molec. Biol. 44, 1−30 (1993). | ChemPort |
2. Hofsteenge, J. et al. Biochemistry 27, 8537−8544 (1988). | Article | PubMed | ISI | ChemPort |
3. Quirin-Stricker, C., Gross, M. & Mandel, P. Biochim. biophys. Acta 159, 75−80 (1968). | PubMed | ChemPort |
4. Shapiro, R. & Vallee, B. L. Proc. natn. Acad. Sci. U.S.A. 84, 2238−2241 (1987). | ChemPort |
5. Kabsch, W. & Sander, C. Biopolymers 22, 2577−2637 (1983). | Article | PubMed | ISI | ChemPort |
6. Lasters, et al. Proc. natn. Acad. Sci. U.S.A. 85, 3338−3342 (1988). | ChemPort |
7. Fominaya, J. M. & Hofsteenge, J. J. biol. Chem. 267, 24655−24660 (1992). | PubMed | ChemPort |
8. McFarland, K. C. et al. Science 245, 494−499 (1989). | PubMed | ISI | ChemPort |
9. Schneider, R. & Schweiger, M. Oncogene 6, 1807−1811 (1991). | PubMed | ISI | ChemPort |
10. Hashimoto, C., Hudson, K. L. & Anderson, K. V. Cell 52, 269−279 (1988). | Article | PubMed | ISI | ChemPort |
11. Reinke, R. et al. Cell 52, 291−301 (1988). | Article | PubMed | ISI | ChemPort |
12. Lopez, J. A. et al. Proc. natn. Acad. Sci. U.S.A. 84, 5615−5619 (1987). | ChemPort |
13. Krusius, T. & Ruoslahti, E. Proc. natn. Acad. Sci. U.S.A. 83, 7683−7687 (1986). | ChemPort |
14. Oldberg, Å et al. EMBO J. 8, 2601−2604 (1989). | PubMed | ISI | ChemPort |
15. Kataoka, T., Broek, D. & Wigler, M. Cell 43, 493−505 (1985). | Article | PubMed | ISI | ChemPort |
16. Tan, F. et al. J. biol. Chem. 265, 13−19 (1990). | PubMed | ChemPort |
17. Leung, K. Y. & Straley, S. C. J. Bact. 171, 4623−4632 (1989). | PubMed | ChemPort |
18. Fresco, L. D., Harper, D. S. & Keene, J. D. Molec cell. Biol. 11, 1578−1589 (1991). | PubMed | ChemPort |
19. Schneider, R. & Schweiger, M. FEBS Lett. 283, 203−206 (1991). | Article | PubMed | ChemPort |
20. Yoder, M. D., Keen, N. T. & Jurnak, F. Science 260, 1503−1507 (1993). | PubMed | ISI | ChemPort |
21. Young, D. et al. Proc. natn. Acad. Sci. U.S.A. 86, 7989−7993 (1989). | ChemPort |
22. Vicentini, A. M. et al. Biochemistry 29, 8827−8834 (1990). | Article | PubMed | ISI | ChemPort |
23. Lee, F. S. & Vallee, B. L. Proc. natn. Acad. Sci. U.S.A. 87, 1879−1883 (1990). | ChemPort |
24. Lee, F. S. & Vallee, B. L. Biochemistry 29, 6633−6638 (1990). | Article | PubMed | ISI | ChemPort |
25. Hofsteenge, J., Vincentini, A. & Stone, S. R. Biochem. J. 275, 541−543 (1991). | PubMed | ISI | ChemPort |
26. Hofsteenge, J., Servis, C. & Stone, S. R. J. biol. Chem. 266, 24198−24204 (1991). | PubMed | ChemPort |
27. Nicholls, A. & Honig, B. J. comp. Chem. 12, 435−445 (1991). | ISI | ChemPort |
28. Kobe, B. & Deisenhofer, J. J. molec. Biol. 231, 137−140 (1993). | Article | PubMed | ChemPort |
29. Neumann, U. et al. J. molec. Biol. 231, 505−508 (1993). | Article | PubMed | ChemPort |
30. Hamlin, R. Meth. Enzym. 114, 416−452 (1985). | PubMed | ChemPort |
31. Howard, A. J., Nielsen, C. & Xuong, N. H. Meth. Enzym. 114, 452−472 (1985). | PubMed | ChemPort |
32. Steigemann, W. PROTEIN: A Program System for the Crystal Structure Analysis of Proteins (Max-Planck-lnstitut für Biochemie, Martinsried, Germany, 1992).
33. Bode, W. & Schirmer, T. Biol. Chem. Hoppe-Seyler 366, 287−295 (1985). | PubMed | ChemPort |
34. Wang, B.-C. Meth. Enzym. 115, 90−112 (1985). | PubMed | ChemPort |
35. Jones, T. A., Bergdoll, M. & Kjeldgaard, M. in Crystallographic and Modeling Methods in Molecular Design (eds Bugg, C. E. & Ealick, S. E.) 189−195 (Springer, New York, 1990). | ChemPort |
36. Brünger, A. T., Kuriyan, J. & Karplus, M. Science 235, 458−460 (1987). | ISI |
37. Luzzati, P. V. Acta crystallogr. 5, 802−810 (1952). | Article | ISI |
38. Read, R. J. Acta crystallogr. A42, 140−149 (1986). | Article | ISI |
39. Carson, M. J. molec. Graphics 5, 105−106 (1987).
40. Wilmot, C. M. & Thornton, J. M. Protein Engng 3, 479−493 (1990). | ChemPort |



© 1993 Nature Publishing Group
Privacy Policy